129 related articles for article (PubMed ID: 25074874)
21. Extra-axial soft tissue chordoma of wrist.
Suzuki H; Yamashiro K; Takeda H; Nojima T; Usui M
Pathol Res Pract; 2011 May; 207(5):327-31. PubMed ID: 21397407
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
23. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
[TBL] [Abstract][Full Text] [Related]
24. [Poorly-differentiated chordoma with INI1 loss: a clinicopathologic study].
Feng JY; Chen L; Ma YY; Yang HW; Chen L
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):695-698. PubMed ID: 29050071
[No Abstract] [Full Text] [Related]
25. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology.
Judkins AR
Adv Anat Pathol; 2007 Sep; 14(5):335-9. PubMed ID: 17717433
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.
O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM
Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540
[TBL] [Abstract][Full Text] [Related]
27. Histological study of chordoma origin from fetal notochordal cell rests.
Shen J; Shi Q; Lu J; Wang DL; Zou TM; Yang HL; Zhu GQ
Spine (Phila Pa 1976); 2013 Dec; 38(25):2165-70. PubMed ID: 24296480
[TBL] [Abstract][Full Text] [Related]
28. Development of a Small Molecule Downmodulator for the Transcription Factor Brachyury.
Chase DH; Bebenek AM; Nie P; Jaime-Figueroa S; Butrin A; Castro DA; Hines J; Linhares BM; Crews CM
Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202316496. PubMed ID: 38348945
[TBL] [Abstract][Full Text] [Related]
29. Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.
Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; De Nictolis M; Santoni M; Montironi R
Pathology; 2014 Dec; 46(7):653-5. PubMed ID: 25393261
[No Abstract] [Full Text] [Related]
30. T gene isoform expression pattern is significantly different between chordomas and notochords.
Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
[TBL] [Abstract][Full Text] [Related]
31. New Prospects for Molecular Targets for Chordomas.
Ozair MZ; Shah PP; Mathios D; Lim M; Moss NS
Neurosurg Clin N Am; 2020 Apr; 31(2):289-300. PubMed ID: 32147018
[TBL] [Abstract][Full Text] [Related]
32. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
Hornick JL; Dal Cin P; Fletcher CD
Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
[TBL] [Abstract][Full Text] [Related]
33. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity.
Sheppard HE; Dall'Agnese A; Park WD; Shamim MH; Dubrulle J; Johnson HL; Stossi F; Cogswell P; Sommer J; Levy J; Sharifnia T; Wawer MJ; Nabet B; Gray NS; Clemons PA; Schreiber SL; Workman P; Young RA; Lin CY
Cell Rep Med; 2021 Jan; 2(1):100188. PubMed ID: 33521702
[TBL] [Abstract][Full Text] [Related]
34. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
[TBL] [Abstract][Full Text] [Related]
35. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
[TBL] [Abstract][Full Text] [Related]
36. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis.
Li L; Fan XS; Xia QY; Rao Q; Liu B; Yu B; Shi QL; Lu ZF; Zhou XJ
Hum Pathol; 2014 Nov; 45(11):2247-54. PubMed ID: 25200863
[TBL] [Abstract][Full Text] [Related]
37. Primary, large extra-axial chordoma in proximal tibia: a rare case report with literature review and diagnostic implications.
Rekhi B
APMIS; 2016 Mar; 124(3):238-42. PubMed ID: 26522887
[TBL] [Abstract][Full Text] [Related]
38. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
[TBL] [Abstract][Full Text] [Related]
39. Poorly differentiated SMARCB1/INI1-negative chordomas.
Zhao J; Feng J; Chen L; Ma Y; Ding D; Wang H
Clin Neuropathol; 2021; 40(1):36-45. PubMed ID: 32631481
[TBL] [Abstract][Full Text] [Related]
40. Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
Yamaguchi T; Imada H; Iida S; Szuhai K
Surg Pathol Clin; 2017 Sep; 10(3):637-656. PubMed ID: 28797506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
